
According to a report on December 15th by Brazilian newspaper, O Globo, Philip Morris Brasil is putting pressure on Brazil's National Health Surveillance Agency (Anvisa) to regulate e-cigarettes in the country.
Last Tuesday (December 12th), Anvisa conducted a public consultation on the issue of e-cigarettes. Philip Morris Brazil quickly launched a voting campaign, advocating for the regulation of electronic products. The campaign was called "I Choose," and it opposed a legislative ban on e-cigarettes, listing reasons supporting the regulation of e-cigarettes.
Philip Morris of Brazil claims that for any smoker, the best choice is to quit smoking. However, if quitting is not possible, they should opt for smokeless products such as e-cigarettes, as these products entail lesser "potential harm" to health.
Rafael Bastos, the Senior Corporate Affairs Manager of Philip Morris Brazil, stated that "smoking e-cigarettes poses significantly less harm to one's health compared to traditional tobacco combustion, which is considered the worst way to consume nicotine.
In addition, he pointed out that currently Anvisa does not know what substances are contained in e-cigarettes, which is also due to the lack of transparency in the illicit market. This issue can be resolved by implementing compliance management for e-cigarettes.
A survey conducted by the investigation agency Ipec reveals that despite a ban on the use of electronic devices since 2009, approximately 2.2 million Brazilians are e-cigarette users.
Philip Morris believes that Brazilian consumers have already made their decision to use their product, regardless of its legality. Therefore, it is necessary to regulate in order to ensure the best possible manner of consumption.
These products are increasingly entering the country, and the reasons for their entry are very clear – because of demand. Today, the smuggling of e-cigarettes is providing funding for criminal gangs," said Bastos.
The public consultation by Anvisa on the subject will continue until February 9, 2024.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com